Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 31, 882-889, June 1, 1971]
© 1971 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Datta, S. K.
Right arrow Articles by Vandeputte, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Datta, S. K.
Right arrow Articles by Vandeputte, M.

Studies on Cellular and Humoral Immunity to Tumor-specific Antigens in Polyoma Virus-induced Tumors of Rats1

Surjit K. Datta and Michel Vandeputte

Rega Institute for Medical Research, University of Leuven, B-3000 Leuven, Belgium

Cellular and humoral immunity against polyoma virus-induced tumors in rats was studied with the colony inhibition assay. Lymph node and spleen cells from syngeneic rats immunized by allogeneic polyoma tumors mediated the immune reaction and reduced the plating efficiency of polyoma target cells, whereas lymph node and spleen cells from syngeneic rats immunized by allogeneic chemical carcinogen [7,12-dimethylbenz(a)anthracene]-induced tumor did not exert an inhibitory effect on plated polyoma tumor cells. Both lymphocytes and sera (in the presence of complement) from animals inoculated at birth with polyoma virus and developing either primary polyoma tumors or no tumors inhibited the colony formation of plated polyoma tumor cells.

Serum from rats showing progressively growing polyoma tumors but not from rats developing no such tumors blocked the inhibitory effect of antipolyoma tumor-immune lymph node and spleen cells used in the colony inhibition assay. The blocking effect of this serum was specific, as it could be removed by absorption with polyoma tumor cells and not with 7,12-dimethylbenz(a)anthracene tumor cells. The sera from rats with primary polyoma tumors might contain blocking factor(s) (antibodies?), which abrogate the inhibitory action of immune lymphocytes, and mediate an efferent form of immunological enhancement, which facilitates the development of primary tumors.

1 This work was supported by a grant from the Belgian "Algemene Spaar-en Lijfrentekas."

Received 10/29/70. Accepted 2/23/71.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1971 by the American Association for Cancer Research.